Skip to main content

Market Overview

Covid-19 Impact on Whole Exome Sequencing Market 2020, Global Industry Size, Development Pipeline, Merger, Growth Analysis, Key Players Statistics

“Whole Exome Sequencing Market”
Whole Exome Sequencing Market: Information by Product (Kits (DNA Fragmentation, End Repair, A-Tailing and Size Selection Kits, Library Preparation, Target Enrichment) Sequencer, Services (Sequencing Services, Data Analysis) Technology (SBS, ION Semiconductor Sequencing) Application (Diagnostics (Cancer Diagnostics, Monogenic Disorders, Monogenic Types Of Diabetes, Others) Drug Discovery And Development, Agriculture and Animal Research) – Global Forecast till 2025

Whole Exome Sequencing Market Analysis

The global whole exome sequencing market is growing at a rapid pace. Market growth attributes to the rising usage of exome in the identification and determination of genetic variants, increasing the chances of diseases such as Miller syndrome and Alzheimer’s. Besides, the decreasing cost of sequencing and the use of whole-exome sequencing technology for varied applications, drive the market growth.

Moreover, increasing product launches and regulatory approvals escalate the growth of the market. According to Market Research Future (MRFR), the global whole exome sequencing market is expected to reach USD 2,696.03 MN by 2025, growing at 19.80% CAGR throughout the forecast period (2019 – 2025). Advantages of whole-exome sequencing procedures increase the market size.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @

Besides, rising advances in sequencing techniques allow the market to garner phenomenal traction on the global platform. Additionally, factors such as increasing cancer research, precision medicine adoption, and evolving complementary industries, foster the market share. Increasing applications such as forensic biology, biotechnology, virology, and molecular biology drive the growth of the whole exome sequencing market.

Conversely, the lack of skilled professionals and legal issues related to whole-exome sequencing are the significant factors projected to impede the market growth. Also, Factors such as insufficient R&D funds and the high cost of development & maintenance inhibit the market growth. Data safety concerns and ethical considerations restrict the growth of the market. Nevertheless, increasing private and public funding programs for R&D would support market growth throughout the review period. 

Whole Exome Sequencing Market   – Segments

The report is segmented into five dynamics;

By Product            : Kits (DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits, Library Preparation, Target Enrichment, others), Sequencer, Services {Sequencing Services, Data Analysis (Bioinformatics), others}, and others.

By Technology     : Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others.

By Application     : Diagnostics {Cancer Diagnostics, Monogenic (Mendelian) Disorders, Monogenic Types of Diabetes, Movement Disorders, HIV, others}, Drug Discovery & Development, Agriculture & Animal Research, and others.

By End User          : Research Centers & Government Institutes, Hospitals & Diagnostics Centers, Pharmaceutical & Biotechnology Companies, and others.

By Regions            :  North America, Europe, APAC, and Rest of the World. 

Whole Exome Sequencing Market   – Regional Analysis

North America dominates the global whole exome sequencing market. The largest market share attributes to the high prevalence rate of cancer & other chronic disorders and high healthcare expenditure. Besides, favorable government initiatives for the development and adoption of whole-exome sequencing technologies drive the growth of the regional market. Moreover, efforts of private organizations aiming to produce genome data for researchers and precision medicine research platforms foster regional market growth.

Additionally, the presence of global players and encouraging research and development in healthcare boost regional market growth. Other factors, such as increased uptake of advanced technologies and high healthcare expenditures, substantiate the growth of the regional market. The US, backed by the rising demands for whole exome sequencing procedures, accounts for the significant growth contributor to the regional market.

Europe stands second in the global whole exome sequencing market. The market is driven by rising cancer cases and increasing programs to promote the adoption of genome sequencing. Moreover, recent advancements in the technology and the augmenting uptake of the advanced technology in the region foster the regional market.

Additionally, the presence of a well-developed medical device industry and rising healthcare expenditure facilitates regional market growth. Also, factors such as the rising support and funding from public & private sectors for research & development fuel the market growth in the region.

The Asia Pacific whole exome sequencing market is emerging as the rapidly growing market, globally. Factors such as the increasing technological advancements, per capita income, and government initiatives to improve healthcare quality, drive the regional market growth.

Furthermore, the growing patient pool and the older population in China, India, and Australia have enabled the regional market to grow promisingly. Also, the rising demand for these whole exome sequencing procedures and the increasing adoption of advanced techniques in these procedures drive the regional market growth. 

Whole Exome Sequencing Market   – Competitive Analysis

Highly competitive, the whole exome sequencing market appears fragmented due to the presence of many well-established players. These players adopt strategic approaches such as mergers & acquisitions, collaboration, expansion, and technology launch to strengthen their market positions. 

They invest substantially in developing new technologies and upgrade their existing sequencing techniques. Also, they make substantial investments to expand their global footprints. 

Whole Exome Sequencing Market Major Players

Players leading the global whole exome sequencing market include BGI (China), Illumina Inc. (US), Eurofins Scientific (Belgium), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Ambry Genetics (US), GENEWIZ (US), Macrogen, Inc. (South Korea), and Integragen SA (France), among others.

Whole Exome Sequencing Industry/Innovations/Related News:

July 22, 2020 —- Swift Biosciences, Inc.(the US), a leader in the commercialization of DNA & RNA library preparation kits for Next-Generation Sequencing (NGS), announced its partnership with Otogenetics Corporation, a high throughput NGS clinical lab to distribute its Swift 2S® Turbo DNA Library Kits. Otogenetics offers prenatal testing, hereditary cancer risk assessment, deafness testing, rare diseases, clinical exome, and other tests for personalized medicine & clinical trials.

The collaboration would help Otogenetics ramp its hereditary disease & personalized medicine service areas and initiatives by supercharging its clinical whole-exome sequencing (WES) offerings. The sequencing of exome allows researchers and clinicians to obtain decision-making data for genetic variants responsible for Mendelian diseases.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India


Press Release Distributed by

To view the original version on ABNewswire visit: Covid-19 Impact on Whole Exome Sequencing Market 2020, Global Industry Size, Development Pipeline, Merger, Growth Analysis, Key Players Statistics

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at